Veranstaltungsprogramm

Eine Übersicht aller Sessions/Sitzungen dieser Tagung.
Bitte wählen Sie einen Ort oder ein Datum aus, um nur die betreffenden Sitzungen anzuzeigen oder eine einzelne Sitzung um die gegebenenfalls vorhandenen Abstracts einsehen zu können.

 
 
Sitzungsübersicht
Datum: Donnerstag, 06.02.2025
10:30
-
12:00
Career Workshop: The importance of a network for your scientific career
Ort: Saal B
Chair: Claudia Göttsch, TU Dresden, Deutschland
Chair: Holger Winkels, Universität zu Köln, Deutschland
12:00
-
12:30
Presidents Opening
Ort: Saal B
Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland
Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland
Chair: Oliver Weingärtner, Universitätsklinikum Jena, Deutschland
12:30
-
13:15
Keynote - Panagiotis Deloukas
Ort: Saal B
Chair: Winfried März, Synlab Holding Deutschland GmbH, Deutschland
Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland
 

Genetic Risk Scores

Panagiotis Deloukas

Oueen Mary University of London, London, Vereinigtes Königreich

13:15
-
13:30
Break / Exhibition / Industry Symposium 13:15 - 14:20
Ort: Foyer
13:30
-
14:20
Kardiovaskuläre Prävention – Zeit zu handeln! - presented by Amgen
Ort: Saal B
Chair: Tienush Rassaf, Universitätsklinikum Essen, Deutschland
 

Kardiovaskuläre Prävention – wo stehen wir in Deutschland?

Amir Abbas Mahabadi

Universitätsklinikum Essen, Essen, Deutschland



Erfolgreiche Integration des Lipidmanagements – Wie wichtig sind funktionierende Versorgungsstrukturen?

Alexander Beck

Praxis für Prävention und kardiovaskuläre Medizin, Essen, Deutschland



Lp(a) – ein unterschätzter Risikofaktor für kardiovaskuläre Erkrankungen?

Ioanna Gouni-Berthold

Universitätsklinikum Köln (AöR), Köln, Deutschland

14:20
-
16:00
Inherited metabolic disorders
Ort: Saal B
Chair: Stefan R. Bornstein, Universitätsklinikum Carl Gustav Carus, Deutschland
Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland
 

The polygenic nature of hypertriglyceridemia

Markus Kleber

Medical Faculty Mannheim at the University of Heidelberg, Mannheim



Genetics of LDL-C- and Lp(a) metabolism

Heribert Schunkert

Deutsches Herzzentrum München, München, Deutschland



Genetics (and Epigenetics) of Diabetes Mellitus

Annette Schürmann

Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, Nuthetal, Deutschland



Genetics of adiposity

Triinu Peters

Universitätsklinikum Essen, Essen, Deutschland

16:00
-
16:15
Break and Exhibition 16:00 - 17:00
Ort: Foyer
16:15
-
17:00
Neueste Fortschritte in der medikamentösen Behandlung von Adipositas bei kardiologischen Patienten – presented by Novo Nordisk
Ort: Saal B
Chair: Shibu Mathew, Universitätsmedizin Essen, Deutschland
 

GLP-1 RA – Eine feste Säule in der kardiovaskulären Prävention?

Ingo Hilgendorf

Universitätsklinikum Freiburg, Freiburg, Deutschland

17:00
-
18:40
Young Investigator Award Session
Ort: Saal B
Chair: Karsten Grote, Philipps-Universität Marburg, Deutschland
Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland
 

Longitudinal Assessment of Sub-clinical Arterial Inflammation in Patients Receiving Immune-Checkpoint Inhibitors by Sequential [18F]FDG PET Scans

Niklas Hempfling, Lucas Bacmeister, Dennis Wolf, Christian Goetz, Dirk Westermann

Uniklinik Freiburg, Freiburg, Germany



Hyperinsulinemia promotes atherosclerosis by inducing metabolic reprogramming of autoreactive CD4+ T cells

Felix Sebastian Nettersheim1,2, Marco Orecchioni1,3, Payel Roy1,3, Monica Billitti1,3, Thomas Riffelmacher1, Mohammad Oliaeimotlagh3, Simon Brunel1, Qingkang Lyu3, Sujit S. Armstrong1, Yuko Tada1, Martina Zoccheddu3, Fabrizio Drago4,5, Coleen A McNamara4,5,6, Chris A Benedict1, Klaus Ley1,3

1: La Jolla Institute for Immunology, La Jolla, CA, USA; 2: Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 3: Immunology Center of Georgia (IMMCG), Augusta University, Augusta, GA, USA; 4: Carter Immunology Center, University of Virginia, Charlottesville, VA, United States; 5: Cardiovascular Research Center, University of Virginia, Charlottesville, VA, United States; 6: Division of Cardiovascular Medicine/Department of Medicine, University of Virginia, Charlottesville, VA, United States



Adenosine deaminase acting on RNA-2 (ADAR2) controls atherosclerosis progression in mice and humans

Michael Amponsah-Offeh1, Simon Tual-Chalot2, Georgios Georgiopoulos3, Kimon Stamatelopoulos3, Konstantinos Stellos1

1: Department of Cardiovascular Research, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; 2: Biosciences Institute, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; 3: Department of Clinical Therapeutics, National and Kapodistrian University of Athens Medical School, Athens, Greece.



Bidirectional crosstalk between macrophages and the heart: drivers of function and dysfunction post-injury.

Tamara Antonela Vico1, Virginia Haacke1, Bianca Dufner1, Stefanie Perez Feliz2, Christoph Koentges3, Tsai-Sang Dederichs1, Alexander von Ehr1, Sebastian Preißl4, Dirk Westermann1, Ingo Hilgendorf1

1: Universitätsklinikum Freiburg, Freiburg, Germany; 2: Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg-Bad Krozingen, Germany; 3: Institute for Disease Modelling and Targeted Medicine (IMITATE), University Clinic Freiburg, Germany; 4: Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany



Intestinal leukocytes regulate cardiac remodeling after myocardial infarction

Nadim Tabaza1, Rutuja Salagundi1, Maximilian Neuhaus1, Naresh Ganesh1, Anmol Kapoor1, Luis Quintana1, Maximilian Sausen1, Martin Reugels1, Katharina Müser1, Maria C. Arrivas1, Susanne Just1, Berkan Kurt1, Jens Spießhoefer2, Kai Markus Schneider3, Angela Schippers4, Holger Winkels5, Norbert Wagner4, Michael Lehrke1, Carolin V. Schneider3, Nikolaus Marx1, Florian Kahles1

1: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin (Medizinische Klinik I), Uniklinik RWTH Aachen, Aachen, Deutschland; 2: Klinik für Pneumologie und Internistische Intensivmedizin (Medizinische Klinik V), Uniklinik RWTH Aachen, Aachen, Deutschland; 3: Klinik für Gastroenterologie, Stoffwechselerkrankungen und Internistische Intensivmedizin (Medizinische Klinik III), Uniklinik RWTH Aachen, Aachen, Deutschland; 4: Klinik für Kinder- und Jugendmedizin, Uniklinik RWTH Aachen, Aachen, Deutschland; 5: Department III of Internal Medicine, Heart Center, University Hospital of Cologne



Accumulation of gut-derived metabolite phenylacetylglutamine in chronic kidney disease promotes cardiac remodeling and is associated with cardiovascular and overall mortality

Maren Gesper1, Andreas Pütz1, Ward Zadora2, Martin Berger1, Henriette de Loor2, Kirsten Thiele1, Philipp Thissen1, Andreas Napp1, Matthias Rau1, Edgar Dahl1, Chao-Chung Kuo4, Julia Franzen4, Katharina Marx-Schütt1, Nikolaus Marx1, Björn Meijers2,3, Ben A. Kappel1

1: Uniklinik RWTH Aachen, Department of Cardiology, Angiology and Critical Care (Medical Clinic 1), Aachen, Germany; 2: Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; 3: Department of Nephrology and Kidney Transplantation, University Hospitals Leuven, Leuven, Belgium; 4: Uniklinik RWTH Aachen, Interdisciplinary Center for Clinical Research (IZKF) Genomics Facility, Aachen, Germany



Characterization of IFNIC macrophages as potential therapeutic target in experimental aneurysm using scRNA- and CITE-sequencing

Christin Elster1, Alexander Lang1, Noura Kharrat1, Miriam Ommer-Bläsius1, Marius Böttenberg1, Susanne Pfeiler1, Tobias Lautwein2, Holger Winkels3, Malte Kelm1, Susanne V. Schmidt4, Norbert Gerdes1

1: Division for Cardiology, Pulmonology and Vascular Medicine, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 2: Genomics and Transcriptomics Laboratory, Biologisch-Medizinisches-Forschungszentrum (BMFZ), Heinrich-Heine University Düsseldorf, Germany; 3: Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 4: Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany

18:40
-
21:00
Poster Session with "Wine & Cheese"
Ort: Foyer
Chair: Yvonne Döring, Universitätsspital Bern, Schweiz
Chair: Michael Torzewski, Robert-Bosch-Krankenhaus GmbH, Deutschland
Chair: Dennis Wolf, Uniklinik Freiburg, Deutschland
Chair: Andreas Zirlik, Medizinische Universität Graz, Österreich
 

C-reactive protein and cardiovascular risk in 454,203 individuals without ASCVD

Berkan Kurt1, Martin Reugels1, Kai Markus Schneider2, Andrea Milzi1, Alessandra Antwerpen1, Konstantin Rex1, Kaan Aygar1, Justus Bornemann1, Naresh Ganesh1, Anna Giacin1, Susanne Just1, Anmol Kapoor1, Marieke Mertens1, Katharina Müser1, Maximilian Neuhaus1, Luis Quintana1, Rutuja Salagundi1, Maximilian Sausen1, Nadim Tabaza1, Alexander Gombert3, Michael Lehrke1, Nikolaus Marx1, Carolin Victoria Schneider2, Florian Kahles1

1: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin (Medizinische Klinik I), Uniklinik RWTH Aachen, Aachen, Deutschland; 2: Klinik für Gastroenterologie, Stoffwechselerkrankungen und Internistische Intensivmedizin (Medizinische Klinik III), Uniklinik RWTH Aachen, Aachen, Deutschland; 3: Klinik für Gefäßchirurgie, Uniklinik RWTH Aachen, Aachen, Deutschland



Characterizing the leukocyte diversity of the arterial vasculature in healthy mice by nuclear and single-cell RNA sequencing

Anton Christian Alexander, Timoteo Marchini, Xiaowei Li, Mark Colin Gissler, Dirk Westermann, Dennis Wolf, - et al

University Hospital Freiburg, Freiburg im Breisgau, Deutschland



CKD triggers enhanced cardiac dysfunction, inflammation and metabolic alterations after myocardial infarction

Corinna Schulte1, Sina Hourtz1, Wollenhaupt Julia1, Möllmann Julia2, Kohlhaas Michael3, Jankowski Vera1, Boor Peter4, Maack Christoph3, Marx Nikolaus2, Noels Heidi1

1: Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, Germany; 2: Department of Internal Medicine I, Cardiology, Uniklinik RWTH Aachen, Aachen, Germany; 3: Department of Translational Research, Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Germany; 4: Institute of Pathology, Uniklinik RWTH Aachen, Aachen, Germany



Comparative Effects of Nano/Microparticles on NF-κB Activation: Implications for Inflammation Beyond Microplastics

Hannes Schiebisch, Michael Malysa, Bernhard Schieffer, Karsten Grote

Cardiology and Angiology, Philipps-University Marburg, Germany



Effect of Myocardial Infarction on the immune response in the melanoma tumor immune microenvironment

Kristel Martinez Lagunas1, Wiebke Kreuzberg1, Katharina Tinaz1, Felix Picard1, Franziska Schneppenheim3, Tobias Bald3, Stephan Baldus1, Holger Winkels1,2

1: Department III of Internal Medicine, Heart Center, University Hospital, University of Cologne, Cologne, Germany; 2: Center for Molecular Medicine Cologne, Cologne, Germany; 3: Institute of Experimental Oncology, University of Bonn, Bonn, Germany



Exposure to dietary α-amylase-trypsin inhibitors (ATI) induces vascular inflammation and endothelial dysfunction

Simon Lange1, Karin Keppeler1, Aline Pesi2, Manjusha Neerukonda2, Henning Ubbens1, Lea Strohm1, Ivana Kuntic1, Marin Kuntic1, Alexandra Rosenberger1, Detlef Schuppan2, Philipp Lurz1, Andreas Daiber1, David Leistner3, Sebastian Steven3

1: Laboratory for Molecular Cardiology, University Hospital Mainz, Germany; 2: Institute of Translational Immunology, University Hospital Mainz, Germany; 3: Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany



Hypercholesterolemia triggers innate immune imbalance and transforms brain infarcts after stroke

Vikramjeet Singh1, Ali Ata Tuz1, Nils Hoerenbaum1, Özgür Ulusoy1, Adel Ahmadi1, Alana Gerlach1, Alexander Beer1, Andreas Kraus1, Anja Hasenberg1, Nina Hagemann3, Dirk M Hermann3, Matthias Gunzer1,2

1: Institute of Experimental Immunology and Imaging, University of Duisburg-Essen, Essen, Germany; 2: Leibniz-Institut für Analytische Wissenschaften - ISAS -e.V., Dortmund, Germany; 3: Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany



Inhibition of B cell activation by Ibrutinib improves cardiac function in experimental myocardial infarction in mice

Xiaowei Li, Timoteo Marchini, Hauke Horstmann, Lucia Mitre, Timothy Mwinyella, Simon Heitlinger, Scheu-Tijiani Abogunloko, Dirk Westmann, Dennis Wolf

University Heart Centre Freiburg-Bad Krozingen, Medical Centre, University of Freiburg, Germany



Kynurenine predicts outcome in pulmonary infections with a link to cardiac dysfunction

Andreas Pütz1, Martin Berger1, Victoria Michalczyk1, Philipp Thissen1, Maren Gesper1, Jens Spiesshoefer2, Philipp Hohlstein3, Alexander Koch3, Henriette de Loor4, Alexander Kersten1, Marlo Verket1, Edgar Dahl5, Andreas Napp1, Matthias Rau1, Michael Dreher2, Björn Meijers4, Nikolaus Marx1, Ben Arpad Kappel1

1: Uniklinik RWTH Aachen, Medizinische Klinik 1, Aachen, Deutschland; 2: Uniklinik RWTH Aachen, Medizinische Klinik 5, Aachen, Deutschland; 3: Uniklinik RWTH Aachen, Medizinische Klinik 3, Aachen, Deutschland; 4: Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; 5: Uniklinik RWTH Aachen, Institut für Pathologie, RWTH centralized Biomaterial Bank, Aachen, Deutschland



Ligature-induced Periodontitis Alters Hematopoiesis and Aggravates Atherosclerotic Plaque Formation in Mice

Samuel Jung1,2,3, Henning Guthoff1,2, Sina Steinhofer1,2,3, Katharina Tinaz1,2,3, Simon Grimm1,2,3, Anton Windfelder5, Matti Adam1,2,3, Stephan Baldus1,2,3, Marc Driessen4, Anna Greta Barbe4, Sonja Henny Maria Derman4, Holger Winkels1,2,3, Martin Mollenhauer1,2,3, Jan Wrobel1,2,3

1: University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany; 2: Center of Cardiovascular Medicine (CCM ABCD) – Aachen, Bonn, Cologne, Düsseldorf; 3: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; 4: Polyclinic for Operative Dentistry and Periodontology, Faculty of Medicine and University Hospital Cologne; 5: Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Gießen



Liver fat content predicts cardiovascular events in 39,953 individuals without ASCVD

Martin Reugels1, Berkan Kurt1, Kai Markus Schneider2,3, Nikolaus Marx1, Carlin Victoria Schneider2,4, Florian Kahles1

1: Department of Internal Medicine I – Cardiology, Angiology and Internal Intensive Care Medicine, University Hospital RWTH Aachen, Germany; 2: Department of Medicine III – Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Germany; 3: Medical Department 1, Technische Universität Dresden, Germany; 4: The Institute for Translational Medicine and Therapeutics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA



Mex3a protects against atherosclerosis: evidence from mice and humans.

James Henderson1,2, Donato Santovito1,2,3

1: Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany; 2: German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Germany; 3: Institute for Genetic and Biomedical Research, Unit of Milan, National Research Council, Italy



Neutrophils Extracellular Traps Myeloperoxidase and Elastase Predict Cerebral Vasospasms after Aneurysmal Subarachnoid Hemorrhage

Saba Sajjad1, Michael Hewera2, Majeed Rana1, Michael Gliem3, Igor Fischer2, Dilaware Khan2

1: Department of Oral, Maxillofacial and Facial Plastic Surgery, University Hospital Düsseldorf, Düsseldorf, Germany; 2: Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Deutschland; 3: Department of Neurology, University Hospital Düsseldorf, Düsseldorf, Germany



Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis

Changjun Yin1,2

1: The first affiliated Hospital of Sun Yat Sen University; 2: Institute for cardiovascular prevention, LMU, Munich



Product problems of in vitro diagnostics for differential diagnostics of myocardial infarction and pulmonary embolism – Analysis of field safety notes published by BfArM between 2014 and 2023

Rüdiger Siekmeier1, Angela Patricia Moissl2, Winfried März3

1: Pharmazeutisches Institut Universität Bonn, Bonn, Deutschland; 2: Institut für Ernährungswissenschaften, Friedrich-Schiller-Universität Jena; 3: Synlab Akademie, Mannheim



Role of complement in adhering platelets and immune cells to endothelium of various organs

Serena Gregori1, Manuela Sauter1, Sonja Ebenhöch2, Frederic Emschermann2, Harald Langer1, Daniel Dürschmied1

1: UMM, Mannheim, Deutschland; 2: Eberhard Karls Universität Tübingen



Senolytic Therapy Reduces IL-6-Mediated Inflammation in the Diabetic Heart

Alexander Lang1, Ashley-Jane Duplessis1, Camila Zöhner1, Diana Klees1, Stephan Angendohr1, Maria Grandoch2, Dennis Sohn3, Malte Kelm1, Norbert Gerdes1

1: 1Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 2: Institute for Translational Pharmacology, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 3: Molecular Radiooncology Clinic for Radiation Therapy and Radiooncology, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany



Senolytics restore diabetes-induced aortic dysfunction in DIO mice

Camila Zöhner1, Diana Klees1, Ashley Duplessis1, Antonia Chira1, Vithya Yogathasan1, Isabella Solga-Kamp1, Lina Hofer1, Ramesh Chennupati1, Julia Duvenbeck1, Maria Grandoch2,3, Elvira Weber4, Hug Aubin4, Malte Kelm2,3, Norbert Gerdes1,3, Alexander Lang1

1: Division of Cardiology, Pulmonology and Vascular Medicine, Düsseldorf, Deutschland; 2: Institute for Translational Pharmacology, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 3: Cardiovascular Research Institute Düsseldorf (CARID), Medical Faculty, Heinrich Heine University, Düsseldorf, Germany; 4: Division of Cardiac Surgery, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Düsseldorf, Germany



Sex-related differences of cardiovascular health in a murine model of celiac disease

Simon Lange1, Karin Keppeler1, Aline Pesi2, Manjusha Neerukonda2, Henning Ubbens1, Lea Strohm1, Ivana Kuntic1, Marin Kuntic1, Alexandra Rosenberger1, Detlef Schuppan2, Philipp Lurz1, Andreas Daiber1, David Leistner3, Sebastian Steven3

1: Laboratory for Molecular Cardiology, University Hospital Mainz, Germany; 2: Institute of Translational Immunology, University Hospital Mainz, Germany; 3: Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany



T regulatory cells (Tregs) lose their protective phenotype in patients with coronary artery disease (CAD)

Timoteo Marchini, Ana-Sophia Burkard, Sophie Hansen, Sheu-Tijani Olawale Abogunloko, Mark Colin Gissler, Dirk Westermann, Dennis Wolf

Universitätsklinikum Freiburg, Freiburg, Germany



The Effects of Fasting on Leukocyte Trafficking in Organ Crosstalk

Naresh Ganesh1, Sikander Hayat2, Anne Babler2, Maximilian Neuhaus1, Nadim Tabaza1, Luis Quintana1, Maximilian Sausen1, Rutuja Salagundi1, Katharina Mueser1, Anmol Kapoor1, Susanne Just1, Maria C. Arrivas1, Berkan Kurt1, Jens Spiesshoefer3, Michael Lehrke1, Jochen Dutzmann4, Daniel Sedding4, Nikolaus Marx1, Rafael Kramann2, Florian Kahles1

1: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin (Medizinische Klinik I), Uniklinik RWTH Aachen, Aachen, Deutschland; 2: Klinik für Nieren- und Hochdruckkrankheiten, Rheumatologische und Immunologische Erkrankungen (Medizinische Klinik II), Uniklinik RWTH Aachen, Aachen, Deutschland; 3: Klinik für Pneumologie und Internistische Intensivmedizin (Medizinische Klinik V), Uniklinik RWTH Aachen, Aachen, Deutschland; 4: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum Halle (Saale), Halle (Saale), Deustchland



The human early atherosclerotic lesion: Insights from Technovit® embedding and integrative imaging

Tipack Ayothyapattanam Shanmugam1, Annemarie Witz1, Julia Theil1, Meng Dong1, Michael Torzewski2

1: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany; 2: Department of Laboratory Medicine and Hospital Hygiene, Robert-Bosch-Hospital, 70376 Stuttgart, Germany



The Role of Enzymatically Modified LDL (eLDL) and Angiopoietin-like Protein 4 (ANGPTL4) in Aortic Valve Stenosis

Annemarie Witz1, Tipack Ayothyapattanam Shanmugam1, Nora Goebel2, Bartosz Rylski2, Michael Torzewski3

1: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP), Stuttgart, Deutschland; 2: Department of Cardiovascular Surgery, Robert-Bosch-Hospital, 70376 Stuttgart, Germany; 3: Department of Laboratory Medicine and Hospital Hygiene, Robert-Bosch-Hospital, 70376 Stuttgart, Germany



The role of Fumarate hydratase 1 (Fh1) in foam cell formation

Jan Wrobel1,2,3, Sina Steinhofer1,2,3, Désirée Schatton4, Mehrnaz Babaki3, Samuel Jung1,2,3, Katharina Tinaz1,2,3, Patrik Schelemei1,2,3, Felix Picard1,2,3, Christian Frezza4,5, Stephan Baldus1,2,3, Holger Winkels1,2,3

1: University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany; 2: Center of Cardiovascular Medicine (CCM ABCD) – Aachen, Bonn, Cologne, Düsseldorf; 3: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; 4: University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute for Metabolomics in Ageing, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany; 5: University of Cologne, Faculty of Mathematics and Natural Sciences, Institute of Genetics, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany



Unraveling T regulatory cell instability and protective immunity loss in murine atherosclerosis

Sheu-Tijani Olawale Abogunloko, Timoteo Marchini, Timothy Myinwella, Fabienne Ehret, Simon Hiltenger, Juana Dominguez, Xiaowei Li, Mark Colin Gissler, Dirk Westermann, Dennis Wolf

Vascular Immunology lab, Department of Cardiology and Angiology, University Heart Centre Freiburg-Bad Krozingen, Freiburg, Germany.



Lipoprotein (a) and Incident Coronary Heart Disease in the Community: Impact of Traditional Cardiovascular Risk Factors

Natalie Arnold, al et

UKE, Hamburg, Hamburg, Deutschland



Assessing the role of olfactory receptor 2 in a diet-induced obesity animal model

Yein Park

University Hospital Cologne, Cologne, Deutschland


Datum: Freitag, 07.02.2025
8:30
-
10:10
The life of the atherosclerotic plaque
Ort: Saal A
Chair: Raluca Mincu, Uniklinikum Essen, Deutschland
Chair: Michael Torzewski, Robert-Bosch-Krankenhaus GmbH, Deutschland
 

Cholesterol efflux pathways, vascular function, and atherosclerosis

Marit Westerterp

University Medical Center Groningen, AV Groningen, Niederlande



Vulnerable atherosclerotic plaques: novel mechanisms and tools to detect them

Isabel Goncalves

Skåne University Hospital, Lund, Schweden



Smooth muscle cells in progressing and regressing atherosclerosis

Jacob Fog Bentzon

Department of Clinical Medicine, Aarhus University



Cellular mechanism of plaque calcification.

Claudia Göttsch

TU Dresden, Deutschland

Screening programs for familial hypercholesterolemia
Ort: Saal B
Chair: Ulrich Paetow, Universitätsklinikum Frankfurt, Deutschland
Chair: Anja Vogt, LMU, Medizinische Klinik IV, Deutschland
 

Experiences from the genetic screening program for FH in the Netherlands (1994 to 2014)

Erik Stroes

Amsterdam UMC, , Niederlande



FH screening: more than 20 years of experiences in the Czech Republic

Michal Vrablik

Charles University, Prague 2, Tschechische Republik



FH screening - insights from the VRONI study

Heribert Schunkert

Deutsches Herzzentrum München, München, Deutschland



FH-Screening - pro

Volker Schettler

Nephrologisches Zentrum Göttingen GbR, Göttingen, Deutschland



FH-Screening - contra

Winfried März

Synlab Holding Deutschland GmbH, Mannheim, Deutschland

10:10
-
10:30
Break and Exhibition 10:10 - 11:15
Ort: Foyer
10:30
-
11:10
Lipidversorgung im Fokus: Wo können wir besser werden? A Call for Action - presented by Daiichi Sankyo
Ort: Saal B
Chair: Christiane Tiefenbacher, MH Wesel, Deutschland
 

Kampagnen für bessere kardiovaskuläre Versorgung

Heribert Schunkert

Deutsches Herzzentrum München, München, Deutschland



Atherosklerose: Früh erkannt - Gefahr gebannt?

Catharina Hamm

Kerckhoff-Klinik, Bad Nauheim, Deutschland



Nachholbedarf? Lipidmanagement bei PAVK-Patienten

Christos Rammos

University of Duisburg Essen, Essen, Deutschland

11:15
-
12:55
Cardiovascular complications of/by atherosclerosis
Ort: Saal A
Chair: Norbert Gerdes, University Hospital Düsseldorf, Deutschland
Chair: Ingo Hilgendorf, Universitätsklinikum Freiburg, Deutschland
 

Cardio-Oncology

Raluca Mincu

Universitätsklinikum Essen, Essen, Deutschland



Autoimmune mechanisms post-MI

Gustavo Ramos

Universitätsklinikum Würzburg



Endocardium as base of inflammation in MI

Florian Leuschner

Universitätsklinikum Heidelberg, Heidelberg, -



Clinical imaging of atherosclerosis

Hendrik Sager

Deutsches Herzzentrum München, München, Deutschland

Cardiovascular risk factors - the obvious and the not so obvious
Ort: Saal B
Chair: Amir Abbas Mahabadi, Universitätsklinikum Essen, Deutschland
Chair: Lars Möller, Universitätsklinikum Essen, Deutschland
 

New guidelines for hypertension

Joachim Hoyer

Universitätsklinikum Marburg, Marburg, Deutschland



Local thyroid hormone action revisited - consequences for metabolism and beyond

Lars Möller

Universitätsklinikum Essen, Essen, Deutschland



Microbiome and cardiovascular diseases

Daniel Messiha

Universitätsklinikum Essen, Essen, Deutschland



The impact of neutrophils on lymphatic microcirculation and post stroke immune suppression.

Matthias Gunzer

Universitätsklinikum Essen, Essen, Deutschland

12:55
-
13:30
Break and Exhibition 12:55 - 14:20
Ort: Foyer
13:30
-
14:20
Strike early and strike strong: Lipidmanagement vor und nach dem Akutereignis - presented by Sanofi
Ort: Saal B
Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland
 

Prevent The First Event - Herzkreislauf-Erkrankungen vorbeugen

Katharina Lechner

Deutsches Herzzentrum München



Prevent The Event - PCSK9-Inhibition nach kardiovaskuläremAkutereignis

Julia Brandts

Universitätsklinik Aachen, Aachen, Deutschland

14:20
-
16:00
Circadian and oscillatory mechanisms of cardiovascular disease
Ort: Saal A
Chair: Berkan Kurt, Uniklinik RWTH Aachen, Deutschland
Chair: Dennis Wolf, Uniklinik Freiburg, Deutschland
 

Increased inflammation due to microplastics

Karsten Grote

Philipps-Universität Marburg, Marburg, Deutschland



New concepts of neutrophil maturation – a matter of location

Oliver Söhnlein

Cells in Motion Interfaculty Centre, Münster, Deutschland



What, when and how much to eat for a healthy heart?

Stefan Lorkowski

Friedrich-Schiller-Universität Jena, Jena, Deutschland



The effect of food on immune cells in health and disease

Florian Kahles

Uniklinikum Aachen, Aachen, Deutschland

Emerging risk factors
Ort: Saal B
Chair: Ioanna Gouni-Berthold, Universitätsklinikum Köln (AöR), Deutschland
Chair: Martin Merkel, Endokrinologikum Hamburg, Deutschland
 

APOC3 and ANGPTL3

Günther Silbernagel

Medical University of Graz, Graz, Österreich



Lipoprotein apheresis in children

Christina Taylan

Universitätsklinikum Köln (AöR), Köln, Deutschland



New RNA-based therapies

Sotirios {Sam} Tsimikas

Sulpizio Cardiovascular Center at UC San Diego Health, BSB 1080, La Jolla, CA, 92093-0682, USA



Remnants - contra

Winfried März

Synlab Holding Deutschland GmbH, Mannheim, Deutschland



Remnants - pro

Børge Nordestgaard

University of Copenhagen, Copenhagen, Denmark

16:00
-
16:15
Break and Exhibition 16:00 - 17:00
Ort: Foyer
16:15
-
17:00
Kontroversen im lipidologischen Alltag: Genetik und Risikoprävention bei Hypertriglyceridämie - presented by Sobi
Ort: Saal B
Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland
 

Genetik sHTG: Werden die genetischen Befunde verstanden?

Winfried März

Synlab Holding Deutschland GmbH, Mannheim, Deutschland



Versorgung: Werden die Triglyceride bei akuter Pankreatitis bestimmt?

Joachim Labenz

Privatpraxis, Siegen, Deutschland



Therapie: Nutzen der ApoC-III Inhibition bei genetischen und klinischen Risikokonstellationen

Ulrike Schatz

Universitätsklinikum Dresden, Dresden, Deutschland

17:00
-
18:00
Awards Session
Ort: Saal B
 

Ehrung für das Lebenswerk Lipidologie durch Verleihung der Chevreul-Medaille der DGFL – Lipid-Liga e. V. an Prof. Dr. Heiner Greten

Gerald Klose

Praxis Dr. Beckenbauer & Dr. Maierhof, Bremen, Deutschland



Verleihung der Schönheimer Medaille der DGAF an Prof. Dr. Dr. Christoph Bode

Daniel Sedding

Universitätsklinikum Halle, Halle, Deutschland



Verleihung des W. H. Hauss-Preis der DGAF an Dr. Hauke Horstmann

Daniel Sedding

Universitätsklinikum Halle, Halle, Deutschland



Cross-Species Single-Cell RNA Sequencing Decodes Adaptive Immunity in Human and Murine Atherosclerosis

Hauke Georg Horstmann

NYU Langone Health, New York, USA

18:00
-
19:00
DGAF Members assembly
Ort: Saal A
19:30
-
22:30
Conference Dinner
Ort: Rosemarie Garten & Bar

Datum: Samstag, 08.02.2025
8:45
-
10:55
Cellular constituents and mechanisms of the atherosclerotic plaque
Ort: Saal B
Chair: Sabine Steffens, LMU München, Deutschland
Chair: Holger Winkels, Universität zu Köln, Deutschland
 

Atherosclerotic plaque fibroblasts originate from adventitial PDGFRA+ progenitor fibroblasts, and a minority acquires a SMC, or macrophage-like fate in the plaque

Judith Sluimer

Department of Pathology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC), Maastricht, The Netherlands



The Aryl Hydrocarbon Receptor (AhR) as novel regulator of atherosclerosis

Emiel van der Vorst

Aachen Maastricht Insitute for CardioRenal Disease (AMICARE), Universitätsklinikum Aachen, Aachen, Deutschland



Regulation of smooth muscle cells in health and disease

Helle Jørgensen

Universitäy of Cambridge, Cambridge, Vereinigtes Königreich



Immunometabolism in the Vascular Wall: New Opportunities to fight Cardiovascular Diseases

Daniel Ketelhuth

University of Southern Denmark - SDU



Haematometabolism rewiring in Atherosclerosis

Laurent Yvan-Charvet

C3M Centre Méditerranéen de Médecine Moléculaire, Nice, Frankreich



Endothelial cell metabolism

Sofia Iris Bibli

European Center for Angioscience, Mannheim, Deutschland

10:55
-
11:15
Break and Exhibition
Ort: Foyer
11:15
-
12:00
Seltene Dyslipidämien und ihre diagnostischen und therapeutischen Herausforderungen - presented by Chiesi
Ort: Saal B
Chair: Anja Vogt, LMU, Medizinische Klinik IV, Deutschland
 

Wenn Fettgewebsverlust zu Hypertriglyceridämie führt - eine Fallvorstellung

Jantje Weiskorn

Auf der Bult, Hannover, Deutschland



Seltene Form der familiären Hypercholesterinämie - eine extreme Herausforderung in der Therapie

Anja Vogt

LMU, Medizinische Klinik IV, München, Deutschland

12:00
-
13:25
Geschlecht und kardiovaskuläre Erkrankungen
Ort: Saal B
Chair: Yvonne Döring, Universitätsspital Bern, Schweiz
Chair: Andreas Zirlik, Medizinische Universität Graz, Österreich
 

Verlust des Y-Chromosoms und kardiovaskuläre Ereignisse bei Chronischer Nierenerkrankung

Thimoteus Speer

Universitätsklinikum Frankfurt, Franfurt a.M., Deutschland



Trans-Gender und kardiovaskuläre Erkrankungen

Lena Seegers

Universitätsklinikum Frankfurt, Frankfurt a.M., Deutschland



Geschlechterspezifische Aspekte bei KHK und in der Lipidologie

Andrea Bäßler

Universitätsklinikum Regensburg, Regensburg, Deutschland

13:25
-
13:45
Young Investigator Awards and Closing remarks
Ort: Saal B
Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland
Chair: Oliver Weingärtner, Universitätsklinikum Jena, Deutschland
Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland